Research Enrolling Studies

Confluence Health’s Clinical Research Department conducts cutting-edge pharmaceutical studies within the guidelines and regulations of the U.S. Food and Drug Administration and good clinical practices (GCPs).

Current Studies:

Patients are currently being recruited for the following research studies. Click on a study name to view details and eligibility. For more information or to inquire about participation, please complete the participant inquiry form.

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)
• Colorectal Cancer Screening Biomarker Study
• Specimen Collection Study to Evaluate Biomarkers in Subjects with Cancer (Exact Sciences)
• Phase 3 Study of Belzuitfan in Combination with Lenvatinib Versus Cabozantinib for Treatment of RCC
• An Open-label, Randomized Phase 3 Study of Immune and Targeted Combination Therapies, as First-line Treatment in Participants with Advanced Clear Cell Renal Cell Carcinoma

Upcoming Studies:

• Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15
• A phase 3, randomized, open-label, multi-country study to evaluate the immunogenicity, safety, reactogenicity and persistence of a single dose of the RSVPreF3 OA investigational vaccine and different revaccination schedules in adults aged 60 years and above (GSK)
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO
• A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the
  Safety and Efficacy of Guselkumab for the Treatment of Participants with Skin of Color who
  have Moderate-to-Severe Plaque Psoriasis and/or Moderate-to-Severe Scalp Psoriasis

Learn About Clinical Research Studies

What are clinical studies?

Clinical research is a scientific study that tests the effectiveness and/or safety of a medical treatment, drug or device with patients. An institutional review board reviews all clinical studies protocols and patient consent documents to ensure patient safety and confidentiality. Clinical studies are well controlled, systematic projects, which give patients an opportunity to participate in cutting-edge medical treatments not yet available on the market.

Will I be compensated?

There are no patient charges for medical services rendered to participants of clinical research studies. Medical tests and physician services associated with the study, in addition to the substance, procedure, or device being tested, are provided to participating patients. Some studies also include a stipend paid to participants for their involvement in the project as reimbursement for time and travel. This amount varies, depending on the nature of the study and the patient involvement. The exception to this is that routine/standard care for oncology studies is frequently billed to third-party payers.

Where can I learn more?

For an overview of clinical studies—including information about the four phases of human clinical studies—please click here.

How do I enroll in a study?

To submit your name for one of our clinical studies, please fill out a participant inquiry form here.